BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15223613)

  • 21. Interleukin-1-dependent sequential chemokine expression and inflammatory cell infiltration in ischemia-reperfusion injury.
    Furuichi K; Wada T; Iwata Y; Kokubo S; Hara A; Yamahana J; Sugaya T; Iwakura Y; Matsushima K; Asano M; Yokoyama H; Kaneko S
    Crit Care Med; 2006 Sep; 34(9):2447-55. PubMed ID: 16849996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Target ablation-induced regulation of macrophage recruitment into the olfactory epithelium of Mip-1alpha-/- mice and restoration of function by exogenous MIP-1alpha.
    Kwong K; Vaishnav RA; Liu Y; Subhedar N; Stromberg AJ; Getchell ML; Getchell TV
    Physiol Genomics; 2004 Dec; 20(1):73-86. PubMed ID: 15467013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis intensified oxidative stress, MIP-1beta and RANTES plasma levels in uraemic patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Cytokine; 2004 Dec; 28(6):197-204. PubMed ID: 15566948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy.
    Göser S; Ottl R; Brodner A; Dengler TJ; Torzewski J; Egashira K; Rose NR; Katus HA; Kaya Z
    Circulation; 2005 Nov; 112(22):3400-7. PubMed ID: 16316965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The chemokines, CX3CL1, CCL14, and CCL4, promote human trophoblast migration at the feto-maternal interface.
    Hannan NJ; Jones RL; White CA; Salamonsen LA
    Biol Reprod; 2006 May; 74(5):896-904. PubMed ID: 16452465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gingival crevicular fluid EMAP-II, MIP-1alpha and MIP-1beta levels of patients with periodontal disease.
    Emingil G; Atilla G; Başkesen A; Berdeli A
    J Clin Periodontol; 2005 Aug; 32(8):880-5. PubMed ID: 15998272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophage inflammatory protein (MIP)1alpha and MIP1beta differentially regulate release of inflammatory cytokines and generation of tumoricidal monocytes in malignancy.
    Nath A; Chattopadhya S; Chattopadhyay U; Sharma NK
    Cancer Immunol Immunother; 2006 Dec; 55(12):1534-41. PubMed ID: 16518599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated levels of fractalkine expression and accumulation of CD16+ monocytes in glomeruli of active lupus nephritis.
    Yoshimoto S; Nakatani K; Iwano M; Asai O; Samejima K; Sakan H; Terada M; Harada K; Akai Y; Shiiki H; Nose M; Saito Y
    Am J Kidney Dis; 2007 Jul; 50(1):47-58. PubMed ID: 17591524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype.
    Brand S; Hofbauer K; Dambacher J; Schnitzler F; Staudinger T; Pfennig S; Seiderer J; Tillack C; Konrad A; Göke B; Ochsenkühn T; Lohse P
    Am J Gastroenterol; 2006 Jan; 101(1):99-106. PubMed ID: 16405540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers.
    Rothenbacher D; Müller-Scholze S; Herder C; Koenig W; Kolb H
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):194-9. PubMed ID: 16239601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dendritic cells modified to express fractalkine/CX3CL1 in the treatment of preexisting tumors.
    Nukiwa M; Andarini S; Zaini J; Xin H; Kanehira M; Suzuki T; Fukuhara T; Mizuguchi H; Hayakawa T; Saijo Y; Nukiwa T; Kikuchi T
    Eur J Immunol; 2006 Apr; 36(4):1019-27. PubMed ID: 16525992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiplex determination of murine seminal fluid cytokine profiles.
    Gopichandran N; Ekbote UV; Walker JJ; Brooke D; Orsi NM
    Reproduction; 2006 Mar; 131(3):613-21. PubMed ID: 16514204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fractalkine gene therapy for neuroblastoma is more effective in combination with targeted IL-2.
    Zeng Y; Jiang J; Huebener N; Wenkel J; Gaedicke G; Xiang R; Lode HN
    Cancer Lett; 2005 Oct; 228(1-2):187-93. PubMed ID: 15953676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy.
    Damås JK; Boullier A; Waehre T; Smith C; Sandberg WJ; Green S; Aukrust P; Quehenberger O
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2567-72. PubMed ID: 16224053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of monocyte chemoattractant protein-1, macrophage inflammatory protein-1alpha and interleukin-1beta in Wallerian degeneration.
    Perrin FE; Lacroix S; Avilés-Trigueros M; David S
    Brain; 2005 Apr; 128(Pt 4):854-66. PubMed ID: 15689362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fractalkine is a novel chemoattractant for rheumatoid arthritis fibroblast-like synoviocyte signaling through MAP kinases and Akt.
    Volin MV; Huynh N; Klosowska K; Chong KK; Woods JM
    Arthritis Rheum; 2007 Aug; 56(8):2512-22. PubMed ID: 17665439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of CCL3/macrophage inflammatory protein-1alpha in experimental colitis.
    Ajuebor MN; Kunkel SL; Hogaboam CM
    Eur J Pharmacol; 2004 Aug; 497(3):343-9. PubMed ID: 15336953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical markers of bone turnover in diagnosis of myeloma bone disease.
    Dizdar O; Barista I; Kalyoncu U; Karadag O; Hascelik G; Cila A; Pinar A; Celik I; Kars A; Tekuzman G
    Am J Hematol; 2007 Mar; 82(3):185-91. PubMed ID: 17022050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T cell costimulation by fractalkine-expressing synoviocytes in rheumatoid arthritis.
    Sawai H; Park YW; Roberson J; Imai T; Goronzy JJ; Weyand CM
    Arthritis Rheum; 2005 May; 52(5):1392-401. PubMed ID: 15880821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin and macrophage protein 1-alpha (MIP-1a) in monoclonal gammopathy of undetermined significance (MGUS).
    Politou M; Terpos E; Anagnostopoulos A; Szydlo R; Laffan M; Layton M; Apperley JF; Dimopoulos MA; Rahemtulla A
    Br J Haematol; 2004 Sep; 126(5):686-9. PubMed ID: 15327520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.